Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer
Table 1
Patients’ baseline characteristics.
Clinical characteristic
Strata
Prevalence n; ()
Age
<65
95 (37,7%)
65-70
68 (27%)
70-75
36 (14,3%)
>75
53 (21%)
ASA
1
60 (23,8%)
2
141 (55,9%)
3
51 (20,3%)
BMI
≤25
72 (28,6%)
25,1-30
112 (44,4%)
30,1-35
40 (15,9%)
>35
17 (6,7%)
missing
11 (4,4%)
Nicotine abuse
yes
115(45,6%)
no
126 (50%)
missing
11 (4,4%)
Prior TURB
0
101 (40%)
1
72 (28,6%)
2
37 (14,7%)
≥3
42 (16,7%)
Rec/year
0
101 (40%)
<1
81 (32,2%)
>1
70 (27,8%)
Preoperative chemotherapy
yes
7 (2,8%)
no
242 (96%)
missing
3 (1,2%)
Preoperative BCG immunotherapy
yes
34 (13,5%)
no
216 (85,7%)
missing
2 (0,8%)
Preoperative hematuria
yes
91 (36,1%)
no
150 (59,5%)
missing
11 (4,4%)
Preoperative pyuria
yes
101 (40,1%)
no
140 (55,5%)
missing
11 (4,4%)
Education
primary
33
secondary/vocational
45
higher
17
missing
5
Marital status
single
11
coupled
59
missing
5
Place of residence
village
62
City <50k
33
City >50k
5
Number of tumors
1
162 (64,3%)
2
39 (15,5%)
≥3
51 (20,2%)
Tumor size
<1cm
91 (36,1%)
1-3cm
108 (42,9%)
>3cm
53 (21%)
Tumour stage (T)
0
35 (14%)
A
111 (44%)
1
56 (22%)
2
32 (12,1%)
Other than UCC
6 (2,4%)
missing
4 (1,6%)
CIS
8 (3,2%)
High grade tumour
yes
87 (34,5%)
no
161 (63,9%)
missing
4 (1,6%)
CIS concomitants
yes
35 (13,9%)
no
213 (84,5%)
missing
4 (1,6%)
Rec: recurrence; ASA: Physical Status Classification System; BMI: Body Mass Index; TURB: transurethral resection of the bladder; BCG: Bacillus Calmette-Guérin; CIS: Carcinoma in situ. Missing data only when indicated.
